In Brief: Encouraging news about ADHD drugs and heart risk in adults

Published: March, 2012

Fast on the heels of a report that drugs for attention deficit hyperactivity disorder (ADHD) do not increase the risk of death from heart disease in children comes another reassuring study — this one in adults.

In a paper published in The Journal of the American Medical Association, researchers report that they analyzed medical records from four health plans in the United States. The sample included 150,000 adults taking stimulant drugs such as methylphenidate (Ritalin) and dextroamphetamine (Adderall) that are commonly used to treat ADHD, and another 300,000 adults not taking these drugs. The researchers found no association between ADHD drugs and heart attack, sudden cardiac death, or stroke.

To continue reading this article, you must log in.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise

New subscriptions to Harvard Health Online are temporarily unavailable. Click the button below to learn about our other subscription offers.

Learn More »